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  Abstract 
    Purpose.   The aim of this paper was to investigate whether cancer genetic counseling could be considered as a stressful event 
and associated with more anxiety and/or depression compared to other cancer-related events for instance attending mam-
mography screening or receiving a cancer diagnosis.   Methods  . A total of 4911 individuals from three Scandinavian countries 
were included in the study. Data was collected from individuals who had attended either cancer genetic counseling (self-
referred and physician-referred) or routine mammography screening, were recalled for a second mammograpy due to a 
suspicious mammogram, had received a cancer diagnosis or had received medical follow-up after a breast cancer-surgery. 
Data from the genetic counseling group was also compared to normative data. Participants ﬁ  lled in the Hospital Anxiety 
and Depression Scale twice: prior to a potentially stressful event and 14 days after the event.   Results.   Pre-counseling cancer 
genetic counselees reported signiﬁ  cant lower level of anxiety compared to the cancer-related group, but higher levels of 
anxiety compared to the general population. Furthermore, the level of depression observed within the genetic counseling 
group was lower compared to other participants. Post-event there was no signiﬁ  cant difference in anxiety levels between 
the cancer genetic counselees and all other groups; however, the level of depression reported in the self-referred group was 
signiﬁ  cantly lower than observed in all other groups. Notably, the level of anxiety and depression had decreased signiﬁ  cantly 
from pre-to post-events within the genetic counseling group. In the cancer-related group only the level of anxiety had 
decreased signiﬁ  cantly post-event.   Conclusion  . Individuals who attend cancer genetic counseling do not suffer more anxiety 
or depression compared to all other cancer-related groups. However, some counselees might need additional sessions and 
extended support. Thus, identifying extremely worried individuals who need more support, and allocating further resources 
to their care, seems to be more sufﬁ  cient.     
  Modern gene technology has made it possible to 
identify individuals at an increased risk for genetic 
diseases. Therefore, since increasing numbers of 
individuals will now desire access to information 
about their genetic risk for developing a disease, 
genetic counseling services have become an integral 
part of specialized health care system. An implicit 
assumption has been that receiving information 
about a potentially life-threatening event, such as a 
cancer diagnosis, may cause psychological and emo-
tional difﬁ   culties, and that genetic counseling may 
facilitate adjustment to this information [1]. Neverthe-
less, information is required regarding the psychosocial 
impact of genetic services upon the individual, 
families and society in general. 
  It is anticipated that in the near future, extensive 
information regarding the genetic transmission of a 
number of diseases will be available and consequently 
genetic counseling will have a substantial impact on 
both the structure and the costs of health services. 
Thus, it seems reasonable that aside from wondering 
whether genetic counseling actually facilitates an indi-
viduals  ’   adjustment and wellbeing, question whether 
there is evidence to indicate that genetic information 
may leads to signiﬁ  cant increases in personal distress 
(anxiety and/or depression). 
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  During the last decade, several systematic reviews 
documenting the psychological impact of learning of 
ones  ’   genetic risk for developing certain illnesses have 
been performed. One of the main conclusions from 
these reviews is that genetic counseling does not have 
any harmful effect on counselees and is effective in 
reducing pre-counseling levels of anxiety, depression 
and distress [2  –  6]. In a Swedish study examining the 
effects of pre-symptomatic testing for breast/ovarian 
and colon cancer susceptibility genes [7] the levels 
of anxiety and depression among mutation carriers 
were compared to both non-carriers and a normative 
Swedish sample. In line with results recently pub-
lished by our research group [8], the results of the 
study by Arver et al. [7] indicated that the carriers 
of the cancer gene had an equal level of anxiety com-
pared to both non-carriers and the normative sample. 
In that study, women being tested for breast cancer 
genes ﬁ  lled in a questionnaire at the time of blood 
sampling prior to the genetic counseling session and 
were reported to have lower levels of depression 
compared to the normative controls. In addition, as 
in the majority of previous studies [2,8–10], the 
results indicated a decrease in the mean level of anx-
iety over time. In a recent review on the psychologi-
cal impact of genetic testing on breast cancer patients 
[6], eight papers published between 1995 and 2004 
were identiﬁ  ed: all indicated that genetic counseling 
was not accompanied by any increase in anxiety or 
depression. However, none of the papers included in 
the Sclich-Bakker review [11  –  18], compared partici-
pants level of distress to normal controls. Moreover, 
controlled studies mostly compare the effect of dif-
ferent types of interventions on study groups or com-
pare the levels of anxiety, depression or distress in 
one group over time [2]. Accordingly, comparing the 
impact of genetic counseling on anxiety and depres-
sion to other potential stressful events, together with 
comparisons between counselees and both the gen-
eral population and other groups within the health 
care system, seems to be both necessary and logical. 
  The main aim of this paper was to study whether 
genetic counseling could be considered as a stressful 
event by the individuals who attend such sessions. 
An additional aim was to explore whether counselees 
were more anxious and/or depressed in comparison 
to other large cancer-related groups within the health 
care systems (e.g. individuals who are referred for 
mammography or those who are treated for cancer 
diseases). 
  The rationale was that if genetic counseling 
attendees were found to be more anxious or 
depressed, then there would be need for psychologi-
cal interventions to explore these emotions in depth. 
Such evidence could then be taken into account 
when planning and allocating resources to the future 
care of individuals who demand information about 
their genetic risk for a particular disease.   
  Participants and methods 
  In the current study, comparisons were made between 
the level of anxiety and depression among individuals 
who attended genetic counseling due to having an 
increased risk for developing cancer; individuals who 
attended mammography screening for non-hereditary 
cancer; various cancer patients and a random sample 
of the general population. 
  Data were collected from Sweden, Norway and 
Denmark, and a total sample of 4911 participants 
was included in the study. Participants from Norway 
were   “  self-referred  ”   to genetic counseling, whilst in 
Sweden and Denmark participants were referred to 
genetic counseling by their primary health care 
physicians. This differences in referral method pre-
sented the opportunity to compare individuals who 
sought genetic counseling in order to receive a risk 
evaluation as a ﬁ   rst step (comparable to primary 
care), to those individuals who were referred to 
genetic counseling by a primary health care physician 
since they were considered to be at an increased risk 
for developing cancer.   
  Standard genetic counseling session 
  In current study, participants attended their ﬁ  rst 
genetic counseling session. During the ﬁ  rst counsel-
ing session, the counselor usually provides informa-
tion regarding the differences between sporadic 
cancer versus hereditary cancer, basic genetics, and 
the risk of developing cancer as a carrier of a mutated 
gene. In addition, the geneticist estimates the risk for 
non-affected counselees  ’   or for affected counselees  ’   
close relatives and supplies information about genetic 
testing and surveillance programs. Counselees who 
undergo genetic testing will attend an additional ses-
sion in association with the disclosure of the test 
results. 
  All participants gave informed consent and the 
study was approved by the Norwegian and Swedish 
Ethical Committee, Danish National Board of Health 
and the Danish Data Protection Agency. 
  The term   “  stressful events  ”   referred to: attending 
genetic counseling, attending a routine mammogra-
phy, being recalled for another mammography 
appointment due to a previous suspicious mammo-
gram, receiving a cancer diagnosis and going for a 
medical follow-up following surgery for cancer. The 
different groups and events are described in more 
detail both below and in Table I. 
  To analyze the data, the sample was divided in three 
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group and the general population group. Data for 
each group is presented separately. Comparisons 
were also made between subgroups of genetic coun-
seling and cancer-related groups. Follow-up data 
(14 days after the event) was not available for all 
participants.       
  Study groups and events   
  The genetic counseling group   
  Counselees referred to the genetic counseling by a physi-
cian.     Participants were recruited between September 
2003 and September 2004 from four genetic outpa-
tient clinics at University Hospitals throughout Den-
mark, and one genetic clinic in Sweden over a period 
of six years (1999 to 2005). The criteria for inclusion 
in the study were an age above 18 years together with 
at least one ﬁ  rst or second degree relatives having 
been diagnosed with breast, breast/ovarian or col-
orectal cancer. Counselees were referred to the 
genetic counseling by a general physician or a spe-
cialist due to being at an increased risk for develop-
ing a hereditary cancer. A consecutive sample of 
674 counselees was included in this group and this 
consisted of 431 participants from Denmark and 
243 participants from Sweden. In Denmark 76% of 
counselees who were asked to participate in the 
study accepted whilst in Sweden 89% of counselees 
agreed to participate. Follow-up data was only avail-
able for the Swedish counselees (n      216; 84%, see 
Table I).     
  Self-referred counselees  .  This group consisted of individu-
als who had sought genetic counseling on their own 
initiative. A total of 275 counselees from three genetic 
out-patient clinics at University Hospitals in Norway 
(Bergen, Trondheim and Stavanger) were asked to par-
ticipate in the study during 2003. Inclusion criteria 
were as described above. A total of 221counselees 
(80%) agreed to participate in the study. The majority 
(65%) had a history of breast- and/or ovarian cancer, 
23% had a history of colorectal cancer and 12% had a 
history of both cancer forms within their families.       
  The cancer-related group   
  The routine mammography screening group  .   A total of 
689 women attending for routine mammography 
screening at two hospitals in Denmark throughout 
2003 and 2004 were asked to participate in the study. 
In total, 61% (n        417) agreed to participate and 
ﬁ  lled out the questionnaire.     
  Women recalled for further examination due to suspicious 
mammograms.     In 1997, 26  086 women attended a 
population-based mammography screening program 
in Uppsala, Sweden. In total, 901 women (3.5%) 
were then recalled for further investigation due to a 
suspect result, for instance a lump in the breast. All 
901 women were asked to participate in the study, 
of which 509 (56%) agreed to and were included.     
  Cancer patients.     Between October 1993 and Decem-
ber 1995, a consecutive group of Swedish patients 
(n      729), that were either newly diagnosed or under 
investigation for breast cancer (n      331); colorectal 
cancer (n      154); gastric cancer (n      47) or prostate 
cancer (n        197), were asked to participate in the 
study. Seventy-two percent of patients (n       527) 
accepted and agreed to participate in the study. A 
subgroup of breast cancer patients (n       149)  had 
ﬁ  lled out the questionnaire before their diagnosis was 
conﬁ   rmed. This created a unique opportunity 
whereby the level of anxiety and depression prior to 
diagnosis could also be assessed. This is often impos-
sible since patients are generally included in studies 
only after having been diagnosed with cancer.     
    Table I. Participants  ’   gender, age and available pre-and post-event HADS  ∗  .   
  Population   N 
  Female 
      gender 
  Age 
      Mean (range) 
  Pre-event 
      HADS         N 
  Post-event 
      HADS         N 
  Genetic counselling 
    Self-referred
        Physician-referred
    221
    674
    81%
    96%
    43 (18  –  78)
    42 (16  –  80)
    213
    655
    186
    216
      Cancer-related group 
Routine mammography 417 100% 55 (26  –  76) 415 0
Recalled after mammography 
    (suspected cancer)
509 100% 54 (40  –  74) 508 0
    Cancer diagnosis     527     61%     64 (32  –  91)     149     484
Medical follow-up after 
breast cancer surgery
45 100% 44 (19  –  52)
    45     42
      General population      2483     89%     52 (25  –  84)     2394     2394
  Total 4911 89% 52  (16  –  91)    
        ∗  HADS: Hospital Anxiety and Depression Scale      .1092   A. Roshanai et al.   
  The medical follow-up group.     During 2000 and 2001 
a group of 72 women diagnosed with breast cancer 
in Sweden, were asked to participate in the study in 
association with their ﬁ  rst medical follow-up after the 
cancer surgery. In total, 63% (n      45) accepted and 
were included in the study. The only criterion for 
inclusion was being younger than 50 years of age at 
the time of diagnosis. This criterion was chosen due 
to a minor increased risk for hereditary cancer, but 
not so high a risk level that makes genetic counseling 
necessary.     
  The general population group.     Normative data on anx-
iety and depression, using The Hospital Anxiety and 
Depression Scale (HADS), were obtained from the 
Nord-Trondelag Health Study (The HUNT-2 
Study) [19]. The HUNT-2 study, one of the largest 
health studies ever conducted, was carried out 
between 1995 and 1997 with a focus on evaluating 
the medical history of individual. Consequently, this 
study now provides a unique database of personal 
and family medical histories. Of 92 936 eligible indi-
viduals, 66 140 (71.2%) participated in the HUNT-2 
study [19]. Nord-Trondelag is one of the 19 counties 
in Norway and comprises 3% of the national popula-
tion. Notably, the county is fairly representative of 
Norway as a whole except for a slightly lower mean 
level of education. Based on the population register, 
all inhabitants in the county aged      20 years were 
invited to participate. Data collection was performed 
using postal questionnaires and a clinical examina-
tion. A random sample of 2483 subjects, from the 
HUNT-2 study with the same proportion of male/
female and the same age range as in the clinical sam-
ple, was included in the present study.       
  Instrument 
  The Hospital Anxiety and Depression Scale (HADS) 
[20] consisting of a seven-item subscale for measur-
ing anxiety (HADS-A) and a seven-item subscale for 
measuring depression (HADS-D), was the instru-
ment chosen to assess symptoms of anxiety and 
depression within this study. Each item has a choice 
of four responses with scores ranging from 0 (no 
symptoms) to 3 (maximum symptoms). The sub-
scale scores range from 0 to 21. The HADS is exten-
sively used and has been demonstrated to possess 
good psychometric properties for use within both the 
normal population, and in somatic, psychiatric, and 
primary care patients [21].     
  Procedure 
  Approximately half of the sample, 2428/4911 indi-
viduals ﬁ  lled out the HADS in connection with a 
potential stress-full event 14 days before the event 
and 14 days after the event. This data was compared 
to the data from a random sample of the general 
population (n      2483). The proportion of men (11%) 
and women (89%) were equal in both samples.     
  Statistical analysis 
  Comparisons of the mean values were performed by 
unpaired two-tailed t-tests. Pre to post-event changes 
were investigated by paired t-tests. T-tests were used 
instead of two-way ANOVA due to lack of follow-up 
data for most participants. Analyses of variance 
(ANOVA) were used for comparison of three or 
more groups. Due to unequal sample sizes, post hoc 
comparisons were performed with the Tukey  ’  s Hon-
estly Signiﬁ  cantly Different (HSD) Unequal Sample 
Sizes test. Post hoc test results are reported only for 
comparisons between genetic counseling group (as a 
whole or as self-referred and physician-referred sub-
groups) and each of the other included groups.       
  Results   
  Between-group comparisons of anxiety 
and depression   
  Pre-event anxiety and depression.     Prior to the stress-full 
event, the genetic counseling group reported signiﬁ  -
cantly lower levels of anxiety (M      5.6), compared 
to the cancer-related group (M        6.9), but higher 
levels of anxiety compared to the general population 
(M      4.4) [F (2.61)      223.3, p      0.001] (Table II). 
However, the level of depression (M      2.7) reported 
by the genetic counseling group was lower compared 
to both the cancer-related group (M      3.4) and the 
general population (M        3.5), [F (2.62)       31.9, 
p      0.001] (Table II).     
  Post-event anxiety and depression.     After counseling, no 
differences in anxiety were observed between the 
genetic counseling group (M      5.0, SD      4.1) and 
the other groups [F (2.54)       17.3,  p      0.001)] 
(Table II). 
  The genetic counseling group reported signiﬁ  -
cantly lower levels of depression (M     2.3, SD      2.9) 
compared to both the cancer-related group and 
general population (M   cancer-related        3.8,  SD      3.7, 
M  general     population        3.5,  SD      3.1)  [F(2.55)      57.3, 
p      0.001] (Table II).       
  Between-subgroup comparisons of anxiety 
and depression 
  The self-referred counselees reported lower levels 
of anxiety both before (M       4.9,  SD      3.6),  and 
after (M       4.4,  SD       3.9) the counseling session    Genetic counseling, anxiety and depression    1093
compared to the physician-referred counselees 
(M   pre-counseling        5.8, SD      4.1, M   post-counseling        5.4, 
SD      4.3). There was no corresponding difference 
for depression between the two groups (Table IV). 
  Prior to the counseling session, both genetic 
counseling subgroups reported lower levels of anxi-
ety compared to most of the other cancer-related 
subgroups and the physician-referred group reported 
higher level of anxiety compared to the general pop-
ulation [F(6.43)      57.3, p      0.001]. No signiﬁ  cant 
differences in anxiety were observed between the 
genetic counseling and the other included groups 
post-counseling [F (3.924)      2.5, P      0.05] (Table 
IVa and b). 
  The genetic counseling subgroups separately 
reported signiﬁ  cantly lower levels of depression both 
pre [F (6.44)      11.9, p      0.001] and post-counseling 
[F(3924)      9.9,  p       0.001] compared to most 
other groups (Table IVa and b). The only exception 
pre-event was that no signiﬁ   cant difference was 
reported by those attending for routine mammogra-
phy and post-event no signiﬁ   cant difference was 
reported between the physician-referred counselees 
and the medical follow-up group (Table IVa and b).     
  Within-group comparisons of anxiety and depression 
(changes over time) 
  Anxiety levels decreased signiﬁ   cantly from pre-
to-post-event measurement in both the genetic coun-
seling group [M  pre-event        5.5,  M  post-event        5.0, 
(t      3.7, p      0.001)], and the cancer-related group 
[M  pre-event        6.7, M  post-event        5.2, SD      4.7, (t      4.6, 
p      0.001)] (Table V). 
    Table II. Participants  ’   mean level of anxiety and depression.    
      Population 
  Pre-event         anxiety 
      Mean (SD) 
  Post-event anxiety 
      Mean (SD) 
  Pre-event         depression 
      Mean (SD) 
  Post-event         depression 
      Mean (SD) 
Genetic counseling group 5.6 (4.0) 5.0 (4.1) 2.7 (3.0) 2.3 (2.9)   
Cancer-related group 6.9 (4.5) 5.1 (4.5) 3.4 (3.2) 3.8 (3.7)   
General population 4.4 (3.4) 4.4 (3.4) 3.5 (3.1) 3.5 (3.1)
    F     223.3  ∗     17.3  ∗     31.9  ∗     57.3  ∗     
      Note: values for normal population were collected once, not pre and post.     
    ∗  p      0.001.     
    Table III. Comparison of the level of anxiety and depression in genetic counseling subgroups pre- and post-event.    
  Population 
  Pre-event         anxiety 
      Mean (SD) 
  Post-event anxiety 
      Mean (SD) 
  Pre-event depression 
      Mean (SD) 
  Post-event         depression 
      Mean (SD) 
Genetic counseling group
      A  - self-referred     4.9 (3.6)     4.4 (3.9)     2.7 (2.9)     2.5 (3.1)
      B-   physician-referred     5.8 (4.1)     5.4 (4.3)     2.6 (3.0)     2.7 (2.9)
Comparison A-B t      2.9  a t       2.4  b t       0.01 t      0.1   
      p      0.001.     
  p      0.05.     
  Furthermore, the level of depression decreased 
signiﬁ   cantly in the genetic counseling group from 
pre-to post- event measurement [M  pre-event        2.9, 
M  post-event        2.6, (t      3.1, p      0.001)]. However, no 
signiﬁ   cant decrease in the level of depression was 
observed in the cancer-related group [M  pre-event        3.8, 
M  post-event        3.6, (t      1.1, p      0.05)] (Table V).     
  Within-subgroup comparisons of anxiety 
and depression (changes over time) 
  The results from analyzing changes in the level of 
both anxiety and depression over time within each 
subgroup indicated that only physician-referred 
counselees reported a signiﬁ   cant reduction in the 
level of anxiety [M  pre-event        6.0,  M  post-event        5.4, 
t      3.6, p      0.001] and depression [M   pre-event        3.2, 
M  post-event        2.7,  (t      3.9,  p       0.001)] over time 
(Table VI). The only other subgroup who reported a 
signiﬁ  cant decrease in anxiety post-event was the can-
cer diagnosis group [M   pre-event        7.0, M  post-event        5.0 
(t      5.1, p      0.001)] (Table VI).       
  Discussion 
  Based on the results of this study, before attending 
counseling, individuals within the genetic counseling 
group, reported signiﬁ  cantly lower level of anxiety 
and depression compared to those in the cancer-
related group and higher levels of anxiety and lower 
level of depression compared to the general popula-
tion. Post-event, there was no difference in the level 
of anxiety between the genetic counseling group and 
the cancer-related group, but the level of depression 1094   A. Roshanai et al.   
    Table IVa. Comparison of the level of anxiety and depression in self-referred counselees with the other included groups.   
  Population 
  Pre-event anxiety 
      Mean (SD) 
  Post-event anxiety 
      Mean (SD) 
  Pre-event depression 
      Mean (SD) 
  Post-event         depression 
      Mean (SD) 
Self-referred counselees 4.9 (3.6) 4.4 (3.9) 2.7 (2.9) 2.5 (3.1)   
Routine mammography 5.9 (4.1)  a 2.9  (3.1)
Recall after mammography     (cancer suspicion) 7.7 (4.5)  b 3.5  (3.1)  a 
Cancer diagnosis 7.0 (4.9)  b  5.0 (4.5) 3.9 (3.9)  b 3.8  (3.7)  b 
Medical follow-up after cancer surgery 6.3 (4.3) 6.0 (4.2) 4.3 (3.5)  a 4.1  (3.6)  a 
General population 4.5 (3.5) 4.5 (3.5) 3.5 (3.1)  b 3.5  (3.1)  b     
      ap      0.05.     
  bp      0.01    . 
    Table IVb. Comparison of the level of anxiety and depression in physician-referred counselees with the other included groups.   
  Population 
  Pre-event anxiety 
      Mean (SD) 
  Post-event anxiety 
      Mean (SD) 
  Pre-event depression 
      Mean (SD) 
  Post-event         depression 
      Mean (SD) 
Physician-referred genetic counselees 5.8 (4.1) 5.4 (4.3) 2.6 (3.0) 2.7 (2.9)
Routine mammography 5.9 (4.1) 2.9 (3.1)
Recall after mammography     (cancer suspicion) 7.7 (4.5)  b 3.5  (3.1)  b 
Cancer diagnosis 7.0 (4.9)  a  5.0 (4.5) 3.9 (3.9)  b 3.8  (3.7)  b 
Medical follow-up after cancer surgery 6.3 (4.4) 6.0 (4.2) 4.3 (3.5)  b 4.1  (3.6)
General population 4.5 (3.5)  b  4.5 (3.5) 3.5 (3.1)  b 3.5  (3.1)  b     
      ap      0.05.     
  bp      0.01      .
    Table V. Within-group comparisons of the level of anxiety and depression over time (paired t-test)  a  .   
  Population 
  Pre-event anxiety 
      Mean (SD) 
  Post-event anxiety 
      Mean (SD)        t-value 
  Pre-event depression   
      Mean (SD) 
  Post-event depression 
      Mean (SD)        t-value 
    Genetic counseling group     5.5 (4.1)     5.0 (4.2)     3.7    ∗       2.9 (3.0)     2.6 (3.0)     3.1    ∗      
Cancer-related group     6.7 (4.7)     5.2 (4.7)     4.6    ∗       3.8 (3.7)     3.6 (3.8)     1.1   
      aNote that different mean values (compared to the Table III) are due to the different number of participant pre to post-event.     
    ∗  p      0.001.     
was still lower than both the cancer-related group 
and the general population. 
  Compared to the general population, the cancer-
related group still reported a higher level of anxiety 
and depression post-event. 
  The level of anxiety and depression had decreased 
signiﬁ   cantly in the genetic counseling group from 
pre-to-post-event measurement. However, this lower 
level of anxiety and depression was only observed in 
the counselees who were referred to the genetic 
counseling by a physician. The other group who 
reported a signiﬁ  cant decrease in anxiety post-event 
was the cancer diagnosis group. 
  The signiﬁ   cantly lower level of anxiety and 
depression reported by the physician-referred coun-
selees post-counseling supports the important role 
played by genetic counseling. 
  Individuals probably experienced high levels of 
unnecessary distress prior to counseling, and atten-
dance at the counseling session may have helped 
them to realize the actual risk and the possibility of 
receiving further help. 
  It was not surprising that the women who were 
recalled for further mammography reported the highest 
levels of anxiety, since uncertainty and being at risk 
of receiving a cancer diagnosis may be considered as 
a very stressful event [22]. 
  Depending on whether genetic counseling is 
primarily considered as a session for delivering precise 
information regarding the genetic risk for a given ill-
ness [23], or is considered in terms of its psychosocial 
elements [24] leads to different conclusions with 
respect to the care to be offered [25]. 
  Genetic counseling is considered as a psycho-
educative process due to the notion that genetic 
information might give rise to a substantial amount 
of psychological distress [1,26,27], and attending 
genetic counseling, as was observed in the current 
study, might reduce any distress experienced [28]. 
  In line with previous studies [9,29,30], our results 
clearly demonstrated that attending genetic counsel-
ing, whether self-referred or following a physician  ’  s 
recommendation, could be related to some distress, 
but was not associated with higher levels of anxiety 
and depression compared to the other kinds of events 
related to the possibility of having cancer (e.g. being 
recalled to mammography), or actually receiving a 
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levels of anxiety and depression. Furthermore, the 
level of anxiety and depression had decreased sig-
niﬁ  cantly in the genetic counseling group from pre-
to-post-event measurement and this may conﬁ  rm 
that any distress experienced is temporary. Also, 
individuals confronted with these types of events 
(attending genetic counseling, and mammography or 
receiving a cancer diagnosis) experience higher levels 
of anxiety compared to the general population, but 
as was observed in previous studies [31,32] this ele-
vation is transient: seeing the doctor or counselor 
leads to a signiﬁ  cant reduction in anxiety. 
  As mentioned earlier, anxiety levels in counselees 
who seek genetic counseling on their own initiative 
was, pre-counseling, signiﬁ  cantly lower than coun-
selees referred to the genetic counseling by a physi-
cian, and compared to most other studied events. 
This is not unexpected since having a suspicious 
mammogram, receiving a cancer diagnosis or being 
operated for breast cancer might be associated with 
higher level of anxiety. Nevertheless, it is possible 
that the lack of signiﬁ  cance in the group of self-re-
ferred counselees could be due to the smaller size of 
this group or because physicians refer individuals 
who have higher risk of developing cancer and are 
more anxious to the counseling to help them to 
receive realistic risk estimation. 
  It is noteworthy that at the time of collecting data 
for the current study, genetic counseling was a rela-
tively new activity. It seems reasonable to speculate 
that this ﬁ  rst wave of individuals who sought coun-
seling on their own probably were more motivated, 
had more information about cancer and perhaps 
were not as anxious or depressed as individuals who 
are referred by another person. As the genetic risk 
evaluation will be used more widely it is reasonable 
to assume that individuals who seek genetic counsel-
ing might not have the same characteristics and will 
require a different type of care. 
  In accordance with an earlier report [7], our 
results indicated that individuals attending genetic 
counseling were signiﬁ  cantly less depressed before 
and after the counseling compared to other patients, 
    Table VI. Within-subgroup comparisons of the level of anxiety and depression over time (paired t-test)  a  .   
      Population 
  Pre-event anxiety 
      Mean (SD) 
  Post-event anxiety 
      Mean (SD)        t 
  Pre-event depression 
      Mean (SD) 
  Post-event depression 
      Mean (SD)        t 
Genetic counselling     self-referred     4.9 (3.6)     4.6 (3.9)     1.7     2.6 (2.8)     2.5 (3.1)     0.6   
Physician-referred 6.0 (4.4) 5.4 (4.3) 3.6       3.2 (3.2) 2.7 (2.9) 3.9    ∗      
    Cancer diagnosis     7.0 (4.9)     5.0 (4.5)     5.1          3.8 (3.9)     3.9 (3.7)     1.3   
Medical follow-up after cancer surgery     5.7 (4.0)     5.8 (4.0)     0.3     3.9 (3.2)     3.9 (3.5)     0.3   
General population  b     4.5 (3.5)     4.5 (3.5)     3.5 (3.1)     3.5 (3.1)
      Note that different mean values (compared to the Table III) are due to the different number of participant pre to post-event.     
  Values for normal population is collected only once, not pre-and post-event.     
    ∗  p      0.001.     
i.e. those who were facing the possibility of receiving 
a cancer diagnosis, those who actually had received 
a diagnosis, and to the general population. This 
result could be due to the fact that individuals who 
seek genetic counseling are actually a selective group 
and posses certain characteristics that were men-
tioned earlier. This also might apply to those who 
are referred by a physician. A considerable propor-
tion of the counselees had high education status, 
were cohabitant individuals who probably have a bet-
ter socioeconomic position, no economical worries, 
plenty of information and a better social network 
which can provide good support. In addition, it is 
reasonable to assume that at-risk individuals who 
have a higher level of distress do not attend genetic 
counseling.   
  Methodological considerations 
  One of the most important strengths of the current 
study is that the results are based on a very large 
sample from different clinics from three Scandina-
vian countries. Furthermore, the study had two 
unique advantages. The ﬁ  rst was the possibility to 
compare self-referred counselees, who probably 
have different characteristics, to individuals who are 
referred to genetic counseling by a physician due 
to being at an increased risk for developing cancer. 
The second was the opportunity of having access 
to data for a subgroup of breast cancer patients 
before their diagnosis was conﬁ  rmed. This made it 
possible to assess the level of anxiety and depression 
pre-diagnosis possible; a variable which is often 
impossible to measure since patients are usually 
included in studies only after having been diagnosed 
by cancer. 
  In addition, psychological distress was assessed 
with a well established instrument proven to have 
good psychometric properties. 
  However, the study is not without limitations and 
the results need to be considered in the light of these 
short-comings. For instance, the homogeneity of the 
groups was not optimal and the date of measurement 1096   A. Roshanai et al.   
was different for various subgroups. However, the 
time points of pre to post-measurements had been 
the same for all groups. 
  The representativeness of women recalled for fur-
ther examination (response rate 56%) may be doubt-
ful and generalization of these results should be done 
with caution due to the selectiveness of the sample. 
The lack of follow-up data is also an undesirable fact 
which may have affected the results.       
  Conclusion 
  Genetic counseling can give rise to some distress, 
though it does not seem to be a more stressful event 
compared to other events within the health care ser-
vice. On the contrary, genetic counseling may be 
associated with some transient elevations of anxiety 
that for most individuals will be handled without the 
requirements for any speciﬁ  c intervention. 
  Considering these results and the ﬁ  ndings of pre-
vious studies indicating that the level of distress in 
genetic counseling counselees decreases over time, 
one plausible conclusion might be that genetic coun-
seling probably helps counselees to cope with their 
cancer or cancer susceptibility over the long term. 
However, some counselees might need additional 
sessions and extended support. Thus, it seems that 
identifying individuals who are extremely worried 
and need more support, and allocating additional 
resources to the care of them, is more important.                     
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NOTICE OF CORRECTION
The Early Online version of this article published 
online ahead of print on 24th of August 2011 con-
tained an error on page 1. The ﬁ  rst author was placed 
as second author. This has been corrected for the 
current version.